Myelosuppression Adult
6 clinical trials · Condition
◉ Watch Myelosuppression Adult
| Record | Firm | Date |
|---|---|---|
| Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab (NCT04887831) | G1 Therapeutics, Inc. | 2021-06-04 |
| Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC): (NCT04607668) | G1 Therapeutics, Inc. | 2021-01-06 |
| G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients (NCT03793205) | Lei Li | 2019-01-03 |
| Long-acting G-CSF for Febrile Neutropenia (NCT03740464) | Lei Li | 2018-11-10 |
Track Myelosuppression Adult automatically
Every clearance here is in the API, with alerts when new ones post.